Login
$XTLB
$1.56 -$0.04 (2.5%) Live

Consolidated Statements of Financial Position

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q4 FY2017
As of Dec 31, 2017
CURRENT ASSETS:
Cash and cash equivalents
Marketable securities – InterCure Ltd.
Trade receivable (net of allowance for credit losses of $0 and $36 at December 31, 2025 and 2024, respectively)
Prepaid expenses and other current assets
Warrants, net
Total current assets
NON-CURRENT ASSETS:
Fixed assets, net
Intangible assets, net
Goodwill
Long-term bank deposit
Total Non-current assets
Total assets
CURRENT LIABILITIES:
Loans and credit from banking corporations
Accounts payable
Warrants, net
Convertible loan from shareholder
Total current liabilities
NON-CURRENT LIABILITIES:
Warrants
Deferred tax liability, net
Total Non-Current liabilities
EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:
Share capital - ordinary shares of NIS 0.1 par value: Authorized December 31, 2025 and 2024 - 1,450,000,000; Issued and outstanding - 946,243,356 on December 31, 2025 and 881,385,256 on December 31, 2024;
Additional paid in capital
Reserve from transactions with non-controlling interests
Accumulated deficit
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support